{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T02:27:56Z","timestamp":1776479276870,"version":"3.51.2"},"reference-count":139,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2014,2,7]],"date-time":"2014-02-07T00:00:00Z","timestamp":1391731200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1007\/s00018-014-1570-y","type":"journal-article","created":{"date-parts":[[2014,2,6]],"date-time":"2014-02-06T08:26:21Z","timestamp":1391675181000},"page":"1789-1798","source":"Crossref","is-referenced-by-count":24,"title":["Hemoglobin as a source of iron overload in multiple sclerosis: does multiple sclerosis share risk factors with vascular disorders?"],"prefix":"10.1007","volume":"71","author":[{"given":"Vladimir V.","family":"Bamm","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Harauz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,2,7]]},"reference":[{"key":"1570_CR1","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0140-6736(02)08220-X","volume":"359","author":"A Compston","year":"2002","unstructured":"Compston A, Coles A (2002) Multiple sclerosis. Lancet 359:1221\u20131231. doi: 10.1016\/S0140-6736(02)08220-X","journal-title":"Lancet"},{"key":"1570_CR2","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1191\/1352458505ms1192oa","volume":"11","author":"CA Beck","year":"2005","unstructured":"Beck CA, Metz LM, Svenson LW, Patten SB (2005) Regional variation of multiple sclerosis prevalence in Canada. Mult Scler 11:516\u2013519","journal-title":"Mult Scler"},{"key":"1570_CR3","first-page":"554","volume":"41","author":"J Charcot","year":"1868","unstructured":"Charcot J (1868) Histologie de la sclerose en plaques. Gazette des Hopitaux (Paris) 41:554\u2013555","journal-title":"Gazette des Hopitaux (Paris)"},{"key":"1570_CR4","first-page":"79","volume":"11","author":"J Murray","year":"2004","unstructured":"Murray J (2004) Prelude to the framing of a disease: multiple sclerosis in the period before Charcots Le\u00e7ons. Int MS J 11:79\u201385","journal-title":"Int MS J"},{"issue":"Supplement 1","key":"1570_CR5","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0022-510X(09)70003-6","volume":"277","author":"TJ Murray","year":"2009","unstructured":"Murray TJ (2009) The history of multiple sclerosis: the changing frame of the disease over the centuries. J Neurol Sci 277(Supplement 1):S3\u2013S8. doi: 10.1016\/S0022-510X(09)70003-6","journal-title":"J Neurol Sci"},{"key":"1570_CR6","first-page":"50","volume":"17","author":"TJ Murray","year":"2011","unstructured":"Murray TJ (2011) Russell brain\u2019s review of MS. Int MS J 17:50\u201353","journal-title":"Int MS J"},{"key":"1570_CR7","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.autrev.2006.02.013","volume":"5","author":"A Achiron","year":"2006","unstructured":"Achiron A (2006) The multiple sclerosis labyrinth\u2014Poirot\u2019s solution. Autoimmun Rev 5:509\u2013510","journal-title":"Autoimmun Rev"},{"key":"1570_CR8","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0092-8674(00)81107-1","volume":"85","author":"L Steinman","year":"1996","unstructured":"Steinman L (1996) Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell 85:299\u2013302","journal-title":"Cell"},{"key":"1570_CR9","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1001\/archneur.61.10.1613","volume":"61","author":"HL Weiner","year":"2004","unstructured":"Weiner HL (2004) Multiple sclerosis is an inflammatory T-cell-mediated autoimmune disease. Arch Neurol 61:1613\u20131615. doi: 10.1001\/archneur.61.10.1613","journal-title":"Arch Neurol"},{"key":"1570_CR10","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.23.021704.115707","volume":"23","author":"M Sospedra","year":"2005","unstructured":"Sospedra M, Martin R (2005) Immunology of multiple sclerosis. Annu Rev Immunol 23:683\u2013747","journal-title":"Annu Rev Immunol"},{"key":"1570_CR11","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.neuron.2006.09.011","volume":"52","author":"SL Hauser","year":"2006","unstructured":"Hauser SL, Oksenberg JR (2006) The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration. Neuron 52:61\u201376. doi: 10.1016\/j.neuron.2006.09.011","journal-title":"Neuron"},{"key":"1570_CR12","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jns.2009.01.018","volume":"282","author":"JJ Geurts","year":"2009","unstructured":"Geurts JJ, Stys PK, Minagar A, Amor S, Zivadinov R (2009) Gray matter pathology in (chronic) MS: modern views on an early observation. J Neurol Sci 282:12\u201320. doi: 10.1016\/j.jns.2009.01.018","journal-title":"J Neurol Sci"},{"key":"1570_CR13","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nrn3275","volume":"13","author":"PK Stys","year":"2012","unstructured":"Stys PK, Zamponi GW, van Minnen J, Geurts JJG (2012) Will the real multiple sclerosis please stand up? Nat Rev Neurosci 13:507\u2013514. doi: 10.1038\/nrn3275","journal-title":"Nat Rev Neurosci"},{"key":"1570_CR14","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1056\/NEJM199801293380502","volume":"338","author":"BD Trapp","year":"1998","unstructured":"Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L (1998) Axonal transection in the lesions of multiple sclerosis. N Engl J Med 338:278\u2013285","journal-title":"N Engl J Med"},{"key":"1570_CR15","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/ana.20016","volume":"55","author":"MH Barnett","year":"2004","unstructured":"Barnett MH, Prineas JW (2004) Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol 55:458\u2013468","journal-title":"Ann Neurol"},{"key":"1570_CR16","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev.neuro.30.051606.094313","volume":"31","author":"BD Trapp","year":"2008","unstructured":"Trapp BD, Nave KA (2008) Multiple sclerosis: an immune or neurodegenerative disorder? Annu Rev Neurosci 31:247\u2013269","journal-title":"Annu Rev Neurosci"},{"key":"1570_CR17","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1016\/j.febslet.2011.08.004","volume":"585","author":"H Lassmann","year":"2011","unstructured":"Lassmann H, van Horssen J (2011) The molecular basis of neurodegeneration in multiple sclerosis. FEBS Lett 585:3715\u20133723. doi: 10.1016\/j.febslet.2011.08.004","journal-title":"FEBS Lett"},{"key":"1570_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2013.05.010","volume":"333","author":"H Lassmann","year":"2013","unstructured":"Lassmann H (2013) Pathology and disease mechanisms in different stages of multiple sclerosis. J Neurol Sci 333:1\u20134. doi: 10.1016\/j.jns.2013.05.010","journal-title":"J Neurol Sci"},{"key":"1570_CR19","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/ana.21800","volume":"66","author":"AP Henderson","year":"2009","unstructured":"Henderson AP, Barnett MH, Parratt JD, Prineas JW (2009) Multiple sclerosis: distribution of inflammatory cells in newly forming lesions. Ann Neurol 66:739\u2013753. doi: 10.1002\/ana.21800","journal-title":"Ann Neurol"},{"key":"1570_CR20","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1017\/S0317167100022393","volume":"37","author":"PK Stys","year":"2010","unstructured":"Stys PK (2010) Multiple sclerosis: autoimmune disease or autoimmune reaction? Can J Neurol Sci 37:S16\u2013S23","journal-title":"Can J Neurol Sci"},{"key":"1570_CR21","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/ana.21845","volume":"66","author":"S Tsutsui","year":"2009","unstructured":"Tsutsui S, Stys PK (2009) Degeneration versus autoimmunity in multiple sclerosis. Ann Neurol 66:711\u2013713. doi: 10.1002\/ana.21845","journal-title":"Ann Neurol"},{"key":"1570_CR22","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.expneurol.2012.04.016","volume":"246","author":"S Tsutsui","year":"2013","unstructured":"Tsutsui S, Stys PK (2013) Metabolic injury to axons and myelin. Exp Neurol 246:26\u201334. doi: 10.1016\/j.expneurol.2012.04.016","journal-title":"Exp Neurol"},{"key":"1570_CR23","first-page":"20","volume":"5","author":"PK Stys","year":"2013","unstructured":"Stys PK (2013) Pathoetiology of multiple sclerosis: are we barking up the wrong tree? F1000Prime Rep 5:20. doi: 10.12703\/P5-20","journal-title":"F1000Prime Rep"},{"key":"1570_CR24","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/bmj.38301.686030.63","volume":"330","author":"CJ Willer","year":"2005","unstructured":"Willer CJ, Dyment DA, Sadovnick AD, Rothwell PM, Murray TJ, Ebers GC (2005) Timing of birth and risk of multiple sclerosis: population based study. BMJ 330:120. doi: 10.1136\/bmj.38301.686030.63","journal-title":"BMJ"},{"key":"1570_CR25","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.clim.2013.05.002","volume":"149","author":"AD Sadovnick","year":"2013","unstructured":"Sadovnick AD (2013) Differential effects of genetic susceptibility factors in males and females with multiple sclerosis. Clin Immunol 149:170\u2013175. doi: 10.1016\/j.clim.2013.05.002","journal-title":"Clin Immunol"},{"key":"1570_CR26","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jneuroim.2012.01.001","volume":"248","author":"P Villoslada","year":"2012","unstructured":"Villoslada P, Baranzini S (2012) Data integration and systems biology approaches for biomarker discovery: challenges and opportunities for multiple sclerosis. J Neuroimmunol 248:58\u201365. doi: 10.1016\/j.jneuroim.2012.01.001","journal-title":"J Neuroimmunol"},{"key":"1570_CR27","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1600-065X.2012.01134.x","volume":"248","author":"PA Gourraud","year":"2012","unstructured":"Gourraud PA, Harbo HF, Hauser SL, Baranzini SE (2012) The genetics of multiple sclerosis: an up-to-date review. Immunol Rev 248:87\u2013103. doi: 10.1111\/j.1600-065X.2012.01134.x","journal-title":"Immunol Rev"},{"key":"1570_CR28","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/WCO.0b013e3283533a93","volume":"25","author":"SE Baranzini","year":"2012","unstructured":"Baranzini SE, Nickles D (2012) Genetics of multiple sclerosis: swimming in an ocean of data. Curr Opin Neurol 25:239\u2013245. doi: 10.1097\/WCO.0b013e3283533a93","journal-title":"Curr Opin Neurol"},{"key":"1570_CR29","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1007\/s00415-013-6873-7","volume":"260","author":"SV Ramagopalan","year":"2013","unstructured":"Ramagopalan SV, Lee JD, Yee IM, Guimond C, Traboulsee AL, Ebers GC, Sadovnick AD (2013) Association of smoking with risk of multiple sclerosis: a population-based study. J Neurol 260:1778\u20131781. doi: 10.1007\/s00415-013-6873-7","journal-title":"J Neurol"},{"key":"1570_CR30","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S1474-4422(12)70309-5","volume":"12","author":"JL Huynh","year":"2013","unstructured":"Huynh JL, Casaccia P (2013) Epigenetic mechanisms in multiple sclerosis: implications for pathogenesis and treatment. Lancet Neurol 12:195\u2013206. doi: 10.1016\/S1474-4422(12)70309-5","journal-title":"Lancet Neurol"},{"key":"1570_CR31","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nn.3588","volume":"17","author":"JL Huynh","year":"2014","unstructured":"Huynh JL, Garg P, Thin TH, Yoo S, Dutta R, Trapp BD, Haroutunian V, Zhu J, Donovan MJ, Sharp AJ, Casaccia P (2014) Epigenome-wide differences in pathology-free regions of multiple sclerosis-affected brains. Nat Neurosci 17:121\u2013130. doi: 10.1038\/nn.3588","journal-title":"Nat Neurosci"},{"key":"1570_CR32","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.1016\/j.febslet.2011.04.006","volume":"585","author":"K Kakalacheva","year":"2011","unstructured":"Kakalacheva K, L\u00fcnemann JD (2011) Environmental triggers of multiple sclerosis. FEBS Lett 585:3724\u20133729. doi: 10.1016\/j.febslet.2011.04.006","journal-title":"FEBS Lett"},{"key":"1570_CR33","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.bbadis.2010.06.012","volume":"1812","author":"K Kakalacheva","year":"2011","unstructured":"Kakalacheva K, Munz C, Lunemann JD (2011) Viral triggers of multiple sclerosis. Biochim Biophys Acta 1812:132\u2013140. doi: 10.1016\/j.bbadis.2010.06.012","journal-title":"Biochim Biophys Acta"},{"key":"1570_CR34","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1177\/1352458509103318","volume":"15","author":"MH Han","year":"2009","unstructured":"Han MH, Steinman L (2009) Systems biology for identification of molecular networks in multiple sclerosis. Mult Scler 15:529\u2013530. doi: 10.1177\/1352458509103318","journal-title":"Mult Scler"},{"key":"1570_CR35","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1093\/hmg\/ddr281","volume":"20","author":"T Tuller","year":"2011","unstructured":"Tuller T, Atar S, Ruppin E, Gurevich M, Achiron A (2011) Global map of physical interactions among differentially expressed genes in multiple sclerosis relapses and remissions. Hum Mol Genet 20:3606\u20133619. doi: 10.1093\/hmg\/ddr281","journal-title":"Hum Mol Genet"},{"key":"1570_CR36","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.copbio.2011.11.009","volume":"23","author":"PM Antony","year":"2012","unstructured":"Antony PM, Balling R, Vlassis N (2012) From systems biology to systems biomedicine. Curr Opin Biotechnol 23:604\u2013608. doi: 10.1016\/j.copbio.2011.11.009","journal-title":"Curr Opin Biotechnol"},{"key":"1570_CR37","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.neuint.2012.11.015","volume":"62","author":"C Funke","year":"2013","unstructured":"Funke C, Schneider SA, Berg D, Kell DB (2013) Genetics and iron in the systems biology of Parkinson\u2019s disease and some related disorders. Neurochem Int 62:637\u2013652. doi: 10.1016\/j.neuint.2012.11.015","journal-title":"Neurochem Int"},{"key":"1570_CR38","doi-asserted-by":"crossref","first-page":"5981","DOI":"10.1111\/febs.12335","volume":"280","author":"PM Antony","year":"2013","unstructured":"Antony PM, Diederich NJ, Kruger R, Balling R (2013) The hallmarks of Parkinson\u2019s disease. FEBS J 280:5981\u20135993. doi: 10.1111\/febs.12335","journal-title":"FEBS J"},{"key":"1570_CR39","doi-asserted-by":"crossref","unstructured":"Fujita KA, Ostaszewski M, Matsuoka Y, Ghosh S, Glaab E, Trefois C, Crespo I, Perumal TM, Jurkowski W, Antony PM, Diederich N, Buttini M, Kodama A, Satagopam VP et al. (2013) Integrating pathways of Parkinson\u2019s disease in a molecular interaction map. Mol Neurobiol. doi: 10.1007\/s12035-013-8489-4","DOI":"10.1007\/s12035-013-8489-4"},{"key":"1570_CR40","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0022-510X(85)90139-X","volume":"69","author":"CW Adams","year":"1985","unstructured":"Adams CW, Poston RN, Buk SJ, Sidhu YS, Vipond H (1985) Inflammatory vasculitis in multiple sclerosis. J Neurol Sci 69:269\u2013283","journal-title":"J Neurol Sci"},{"key":"1570_CR41","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1136\/jnnp.51.2.260","volume":"51","author":"CW Adams","year":"1988","unstructured":"Adams CW (1988) Perivascular iron deposition and other vascular damage in multiple sclerosis. J Neurol Neurosurg Psychiatry 51:260\u2013265","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1570_CR42","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1148\/radiol.2313030996","volume":"231","author":"M Law","year":"2004","unstructured":"Law M, Saindane AM, Ge Y, Babb JS, Johnson G, Mannon LJ, Herbert J, Grossman RI (2004) Microvascular abnormality in relapsing-remitting multiple sclerosis: perfusion MR imaging findings in normal-appearing white matter. Radiology 231:645\u2013652. doi: 10.1148\/radiol.2313030996","journal-title":"Radiology"},{"key":"1570_CR43","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3181\/00379727-165-40980","volume":"165","author":"W Craelius","year":"1980","unstructured":"Craelius W, Jacobs RM, Jones AO (1980) Mineral composition of brains of normal and multiple sclerosis victims. Proc Soc Exp Biol Med 165:327\u2013329","journal-title":"Proc Soc Exp Biol Med"},{"key":"1570_CR44","first-page":"397","volume":"106","author":"W Craelius","year":"1982","unstructured":"Craelius W, Migdal MW, Luessenhop CP, Sugar A, Mihalakis I (1982) Iron deposits surrounding multiple sclerosis plaques. Arch Pathol Lab Med 106:397\u2013399","journal-title":"Arch Pathol Lab Med"},{"key":"1570_CR45","first-page":"755","volume":"108","author":"JC Walton","year":"1984","unstructured":"Walton JC, Kaufmann JC (1984) Iron deposits and multiple sclerosis. Arch Pathol Lab Med 108:755\u2013756","journal-title":"Arch Pathol Lab Med"},{"key":"1570_CR46","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1258\/jrsm.99.11.589","volume":"99","author":"P Zamboni","year":"2006","unstructured":"Zamboni P (2006) The big idea: iron-dependent inflammation in venous disease and proposed parallels in multiple sclerosis. J R Soc Med 99:589\u2013593. doi: 10.1258\/jrsm.99.11.589","journal-title":"J R Soc Med"},{"key":"1570_CR47","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/jmri.21676","volume":"29","author":"EM Haacke","year":"2009","unstructured":"Haacke EM, Makki M, Ge Y, Maheshwari M, Sehgal V, Hu J, Selvan M, Wu Z, Latif Z, Xuan Y, Khan O, Garbern J, Grossman RI (2009) Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging. J Magn Reson Imaging 29:537\u2013544. doi: 10.1002\/jmri.21676","journal-title":"J Magn Reson Imaging"},{"key":"1570_CR48","first-page":"149","volume":"29","author":"EM Haacke","year":"2010","unstructured":"Haacke EM, Garbern J, Miao Y, Habib C, Liu M (2010) Iron stores and cerebral veins in MS studied by susceptibility weighted imaging. Int Angiol 29:149\u2013157 R34102502 [pii]","journal-title":"Int Angiol"},{"key":"1570_CR49","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/jmri.22276","volume":"32","author":"EM Haacke","year":"2010","unstructured":"Haacke EM, Tang J, Neelavalli J, Cheng YC (2010) Susceptibility mapping as a means to visualize veins and quantify oxygen saturation. J Magn Reson Imaging 32:663\u2013676. doi: 10.1002\/jmri.22276","journal-title":"J Magn Reson Imaging"},{"key":"1570_CR50","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1586\/ern.10.174","volume":"11","author":"EM Haacke","year":"2011","unstructured":"Haacke EM (2011) Chronic cerebral spinal venous insufficiency in multiple sclerosis. Expert Rev Neurother 11:5\u20139. doi: 10.1586\/ern.10.174","journal-title":"Expert Rev Neurother"},{"key":"1570_CR51","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1093\/brain\/awr278","volume":"134","author":"F Bagnato","year":"2011","unstructured":"Bagnato F, Hametner S, Yao B, van Gelderen P, Merkle H, Cantor FK, Lassmann H, Duyn JH (2011) Tracking iron in multiple sclerosis: a combined imaging and histopathological study at 7 Tesla. Brain 134:3602\u20133615. doi: 10.1093\/brain\/awr278","journal-title":"Brain"},{"key":"1570_CR52","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/2040-7378-3-7","volume":"3","author":"A Waschbisch","year":"2011","unstructured":"Waschbisch A, Manzel A, Linker RA, Lee DH (2011) Vascular pathology in multiple sclerosis: mind boosting or myth busting? Exp Transl Stroke Med 3:7. doi: 10.1186\/2040-7378-3-7","journal-title":"Exp Transl Stroke Med"},{"key":"1570_CR53","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3174\/ajnr.A2773","volume":"33","author":"CA Habib","year":"2012","unstructured":"Habib CA, Liu M, Bawany N, Garbern J, Krumbein I, Mentzel HJ, Reichenbach J, Magnano C, Zivadinov R, Haacke EM (2012) Assessing abnormal iron content in the deep gray matter of patients with multiple sclerosis versus healthy controls. AJNR Am J Neuroradiol 33:252\u2013258. doi: 10.3174\/ajnr.A2773","journal-title":"AJNR Am J Neuroradiol"},{"key":"1570_CR54","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1471-4159.2012.07934.x","volume":"123","author":"H Gonzalo","year":"2012","unstructured":"Gonzalo H, Brieva L, Tatzber F, Jove M, Cacabelos D, Cassanye A, Lanau-Angulo L, Boada J, Serrano JC, Gonzalez C, Hernandez L, Peralta S, Pamplona R, Portero-Otin M (2012) Lipidome analysis in multiple sclerosis reveals protein lipoxidative damage as a potential pathogenic mechanism. J Neurochem 123:622\u2013634. doi: 10.1111\/j.1471-4159.2012.07934.x","journal-title":"J Neurochem"},{"key":"1570_CR55","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1177\/1352458512465135","volume":"19","author":"AM Al-Radaideh","year":"2013","unstructured":"Al-Radaideh AM, Wharton SJ, Lim SY, Tench CR, Morgan PS, Bowtell RW, Constantinescu CS, Gowland PA (2013) Increased iron accumulation occurs in the earliest stages of demyelinating disease: an ultra-high field susceptibility mapping study in clinically isolated syndrome. Mult Scler 19:896\u2013903. doi: 10.1177\/1352458512465135","journal-title":"Mult Scler"},{"key":"1570_CR56","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1148\/radiol.10101387","volume":"258","author":"R Zivadinov","year":"2011","unstructured":"Zivadinov R, Lopez-Soriano A, Weinstock-Guttman B, Schirda CV, Magnano CR, Dolic K, Kennedy CL, Brooks CL, Reuther JA, Hunt K, Andrews M, Dwyer MG, Hojnacki DW (2011) Use of MR venography for characterization of the extracranial venous system in patients with multiple sclerosis and healthy control subjects. Radiology 258:562\u2013570. doi: 10.1148\/radiol.10101387","journal-title":"Radiology"},{"key":"1570_CR57","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/glia.20784","volume":"57","author":"B Todorich","year":"2009","unstructured":"Todorich B, Pasquini JM, Garcia CI, Paez PM, Connor JR (2009) Oligodendrocytes and myelination: the role of iron. Glia 57:467\u2013478. doi: 10.1002\/glia.20784","journal-title":"Glia"},{"key":"1570_CR58","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/biof.90","volume":"36","author":"ME Badaracco","year":"2010","unstructured":"Badaracco ME, Siri MV, Pasquini JM (2010) Oligodendrogenesis: the role of iron. BioFactors 36:98\u2013102. doi: 10.1002\/biof.90","journal-title":"BioFactors"},{"key":"1570_CR59","doi-asserted-by":"crossref","first-page":"13301","DOI":"10.1523\/JNEUROSCI.2838-11.2011","volume":"31","author":"K Schulz","year":"2011","unstructured":"Schulz K, Vulpe CD, Harris LZ, David S (2011) Iron efflux from oligodendrocytes is differentially regulated in gray and white matter. J Neurosci 31:13301\u201313311. doi: 10.1523\/JNEUROSCI.2838-11.2011","journal-title":"J Neurosci"},{"key":"1570_CR60","doi-asserted-by":"crossref","first-page":"4841","DOI":"10.1523\/JNEUROSCI.5328-11.2012","volume":"32","author":"K Schulz","year":"2012","unstructured":"Schulz K, Kroner A, David S (2012) Iron efflux from astrocytes plays a role in remyelination. J Neurosci 32:4841\u20134847. doi: 10.1523\/JNEUROSCI.5328-11.2012","journal-title":"J Neurosci"},{"key":"1570_CR61","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1471-4159.2011.07536.x","volume":"120","author":"R Williams","year":"2012","unstructured":"Williams R, Buchheit CL, Berman NE, LeVine SM (2012) Pathogenic implications of iron accumulation in multiple sclerosis. J Neurochem 120:7\u201325. doi: 10.1111\/j.1471-4159.2011.07536.x","journal-title":"J Neurochem"},{"key":"1570_CR62","doi-asserted-by":"crossref","unstructured":"Hametner S, Wimmer I, Haider L, Pfeifenbring S, Bruck W, Lassmann H (2013) Iron and neurodegeneration in the multiple sclerosis brain. Ann Neurol. doi: 10.1002\/ana.23974","DOI":"10.1002\/ana.23974"},{"key":"1570_CR63","doi-asserted-by":"crossref","unstructured":"Weigel KJ, Lynch SG, LeVine SM (2014) Iron chelation and multiple sclerosis. ASN Neuro. doi: 10.1042\/AN20130037","DOI":"10.1042\/AN20130037"},{"key":"1570_CR64","doi-asserted-by":"crossref","first-page":"17587","DOI":"10.1523\/JNEUROSCI.3241-13.2013","volume":"33","author":"M Schwartz","year":"2013","unstructured":"Schwartz M, Kipnis J, Rivest S, Prat A (2013) How do immune cells support and shape the brain in health, disease, and aging? J Neurosci 33:17587\u201317596. doi: 10.1523\/JNEUROSCI.3241-13.2013","journal-title":"J Neurosci"},{"key":"1570_CR65","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/jcbfm.2012.153","volume":"33","author":"LL Muldoon","year":"2013","unstructured":"Muldoon LL, Alvarez JI, Begley DJ, Boado RJ, Del Zoppo GJ, Doolittle ND, Engelhardt B, Hallenbeck JM, Lonser RR, Ohlfest JR, Prat A, Scarpa M, Smeyne RJ, Drewes LR et al (2013) Immunologic privilege in the central nervous system and the blood\u2013brain barrier. J Cereb Blood Flow Metab 33:13\u201321. doi: 10.1038\/jcbfm.2012.153","journal-title":"J Cereb Blood Flow Metab"},{"key":"1570_CR66","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1552-6569.2008.00296.x","volume":"19","author":"M Neema","year":"2009","unstructured":"Neema M, Arora A, Healy BC, Guss ZD, Brass SD, Duan Y, Buckle GJ, Glanz BI, Stazzone L, Khoury SJ, Weiner HL, Guttmann CR, Bakshi R (2009) Deep gray matter involvement on brain MRI scans is associated with clinical progression in multiple sclerosis. J Neuroimaging 19:3\u20138. doi: 10.1111\/j.1552-6569.2008.00296.x","journal-title":"J Neuroimaging"},{"key":"1570_CR67","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1471-2350-13-70","volume":"13","author":"D Gemmati","year":"2012","unstructured":"Gemmati D, Zeri G, Orioli E, De Gaetano FE, Salvi F, Bartolomei I, D\u2019alfonso S, Dall\u2019osso C, Leone MA, Singh AV, Asselta R, Zamboni P (2012) Polymorphisms in the genes coding for iron binding and transporting proteins are associated with disability, severity, and early progression in multiple sclerosis. BMC Med Genet 13:70. doi: 10.1186\/1471-2350-13-70","journal-title":"BMC Med Genet"},{"key":"1570_CR68","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1471-4159.2009.06470.x","volume":"112","author":"DW Lee","year":"2010","unstructured":"Lee DW, Andersen JK (2010) Iron elevations in the aging Parkinsonian brain: a consequence of impaired iron homeostasis? J Neurochem 112:332\u2013339. doi: 10.1111\/j.1471-4159.2009.06470.x","journal-title":"J Neurochem"},{"key":"1570_CR69","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1586\/ern.12.128","volume":"12","author":"J Hagemeier","year":"2012","unstructured":"Hagemeier J, Geurts JJ, Zivadinov R (2012) Brain iron accumulation in aging and neurodegenerative disorders. Expert Rev Neurother 12:1467\u20131480. doi: 10.1586\/ern.12.128","journal-title":"Expert Rev Neurother"},{"key":"1570_CR70","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.nbd.2012.03.006","volume":"46","author":"R Prohaska","year":"2012","unstructured":"Prohaska R, Sibon OC, Rudnicki DD, Danek A, Hayflick SJ, Verhaag EM, Vonk JJ, Margolis RL, Walker RH (2012) Brain, blood, and iron: perspectives on the roles of erythrocytes and iron in neurodegeneration. Neurobiol Dis 46:607\u2013624. doi: 10.1016\/j.nbd.2012.03.006","journal-title":"Neurobiol Dis"},{"key":"1570_CR71","doi-asserted-by":"crossref","first-page":"879","DOI":"10.3233\/JAD-2009-1010","volume":"16","author":"S Altamura","year":"2009","unstructured":"Altamura S, Muckenthaler MU (2009) Iron toxicity in diseases of aging: Alzheimer\u2019s disease, Parkinson\u2019s disease and atherosclerosis. J Alzheimers Dis 16:879\u2013895. doi: 10.3233\/JAD-2009-1010","journal-title":"J Alzheimers Dis"},{"key":"1570_CR72","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/jnc.12165","volume":"125","author":"P Hahl","year":"2013","unstructured":"Hahl P, Davis T, Washburn C, Rogers JT, Smith A (2013) Mechanisms of neuroprotection by hemopexin: modeling the control of heme and iron homeostasis in brain neurons in inflammatory states. J Neurochem 125:89\u2013101. doi: 10.1111\/jnc.12165","journal-title":"J Neurochem"},{"key":"1570_CR73","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1089\/ars.2009.2929","volume":"13","author":"O Weinreb","year":"2010","unstructured":"Weinreb O, Amit T, Mandel S, Kupershmidt L, Youdim MB (2010) Neuroprotective multifunctional iron chelators: from redox-sensitive process to novel therapeutic opportunities. Antioxid Redox Signal 13:919\u2013949. doi: 10.1089\/ars.2009.2929","journal-title":"Antioxid Redox Signal"},{"key":"1570_CR74","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1471-2202-12-59","volume":"12","author":"R Williams","year":"2011","unstructured":"Williams R, Rohr AM, Wang WT, Choi IY, Lee P, Berman NE, Lynch SG, LeVine SM (2011) Iron deposition is independent of cellular inflammation in a cerebral model of multiple sclerosis. BMC Neurosci 12:59. doi: 10.1186\/1471-2202-12-59","journal-title":"BMC Neurosci"},{"key":"1570_CR75","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.nurt.2007.05.006","volume":"4","author":"J Stankiewicz","year":"2007","unstructured":"Stankiewicz J, Panter SS, Neema M, Arora A, Batt CE, Bakshi R (2007) Iron in chronic brain disorders: imaging and neurotherapeutic implications. Neurotherapeutics 4:371\u2013386. doi: 10.1016\/j.nurt.2007.05.006","journal-title":"Neurotherapeutics"},{"key":"1570_CR76","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/jmri.23603","volume":"36","author":"J Hagemeier","year":"2012","unstructured":"Hagemeier J, Heininen-Brown M, Poloni GU, Bergsland N, Magnano CR, Durfee J, Kennedy C, Carl E, Weinstock-Guttman B, Dwyer MG, Zivadinov R (2012) Iron deposition in multiple sclerosis lesions measured by susceptibility-weighted imaging filtered phase: a case control study. J Magn Reson Imaging 36:73\u201383. doi: 10.1002\/jmri.23603","journal-title":"J Magn Reson Imaging"},{"key":"1570_CR77","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.mri.2012.11.011","volume":"31","author":"F Bagnato","year":"2013","unstructured":"Bagnato F, Hametner S, Welch EB (2013) Visualizing iron in multiple sclerosis. Magn Reson Imaging 31:376\u2013384. doi: 10.1016\/j.mri.2012.11.011","journal-title":"Magn Reson Imaging"},{"key":"1570_CR78","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1177\/1352458512459289","volume":"19","author":"J Hagemeier","year":"2013","unstructured":"Hagemeier J, Yeh EA, Brown MH, Bergsland N, Dwyer MG, Carl E, Weinstock-Guttman B, Zivadinov R (2013) Iron content of the pulvinar nucleus of the thalamus is increased in adolescent multiple sclerosis. Mult Scler 19:567\u2013576. doi: 10.1177\/1352458512459289","journal-title":"Mult Scler"},{"key":"1570_CR79","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.3174\/ajnr.A3030","volume":"33","author":"J Hagemeier","year":"2012","unstructured":"Hagemeier J, Weinstock-Guttman B, Bergsland N, Heininen-Brown M, Carl E, Kennedy C, Magnano C, Hojnacki D, Dwyer MG, Zivadinov R (2012) Iron deposition on SWI-filtered phase in the subcortical deep gray matter of patients with clinically isolated syndrome may precede structure-specific atrophy. AJNR Am J Neuroradiol 33:1596\u20131601. doi: 10.3174\/ajnr.A3030","journal-title":"AJNR Am J Neuroradiol"},{"key":"1570_CR80","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1093\/jn\/133.8.2635","volume":"133","author":"SM Grant","year":"2003","unstructured":"Grant SM, Wiesinger JA, Beard JL, Cantorna MT (2003) Iron-deficient mice fail to develop autoimmune encephalomyelitis. J Nutr 133:2635\u20132638","journal-title":"J Nutr"},{"key":"1570_CR81","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1177\/1352458512460602","volume":"19","author":"N Nathoo","year":"2013","unstructured":"Nathoo N, Agrawal S, Wu Y, Haylock-Jacobs S, Yong VW, Foniok T, Barnes S, Obenaus A, Dunn JF (2013) Susceptibility-weighted imaging in the experimental autoimmune encephalomyelitis model of multiple sclerosis indicates elevated deoxyhemoglobin, iron deposition and demyelination. Mult Scler J 19:721\u2013731. doi: 10.1177\/1352458512460602","journal-title":"Mult Scler J"},{"key":"1570_CR82","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1084\/jem.160.5.1532","volume":"160","author":"N Bowern","year":"1984","unstructured":"Bowern N, Ramshaw IA, Clark IA, Doherty PC (1984) Inhibition of autoimmune neuropathological process by treatment with an iron-chelating agent. J Exp Med 160:1532\u20131543","journal-title":"J Exp Med"},{"key":"1570_CR83","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0165-5728(97)00256-7","volume":"84","author":"TV Pedchenko","year":"1998","unstructured":"Pedchenko TV, LeVine SM (1998) Desferrioxamine suppresses experimental allergic encephalomyelitis induced by MBP in SJL mice. J Neuroimmunol 84:188\u2013197 S0165-5728(97)00256-7 [pii]","journal-title":"J Neuroimmunol"},{"key":"1570_CR84","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000065694","volume":"24","author":"SM LeVine","year":"2002","unstructured":"LeVine SM, Maiti S, Emerson MR, Pedchenko TV (2002) Apoferritin attenuates experimental allergic encephalomyelitis in SJL mice. Dev Neurosci 24:177\u2013183. doi: 10.1159\/000065694","journal-title":"Dev Neurosci"},{"key":"1570_CR85","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1177\/1352458507078916","volume":"13","author":"KM Mitchell","year":"2007","unstructured":"Mitchell KM, Dotson AL, Cool KM, Chakrabarty A, Benedict SH, LeVine SM (2007) Deferiprone, an orally deliverable iron chelator, ameliorates experimental autoimmune encephalomyelitis. Mult Scler 13:1118\u20131126. doi: 10.1177\/1352458507078916","journal-title":"Mult Scler"},{"key":"1570_CR86","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.nbd.2013.01.012","volume":"54","author":"BY Choi","year":"2013","unstructured":"Choi BY, Jang BG, Kim JH, Seo JN, Wu G, Sohn M, Chung TN, Suh SW (2013) Copper\/zinc chelation by clioquinol reduces spinal cord white matter damage and behavioral deficits in a murine MOG-induced multiple sclerosis model. Neurobiol Dis 54:382\u2013391. doi: 10.1016\/j.nbd.2013.01.012","journal-title":"Neurobiol Dis"},{"key":"1570_CR87","doi-asserted-by":"crossref","first-page":"29582","DOI":"10.1074\/jbc.M109.045344","volume":"284","author":"G Silva","year":"2009","unstructured":"Silva G, Jeney V, Chora A, Larsen R, Balla J, Soares MP (2009) Oxidized hemoglobin is an endogenous proinflammatory agonist that targets vascular endothelial cells. J Biol Chem 284:29582\u201329595. doi: 10.1074\/jbc.M109.045344","journal-title":"J Biol Chem"},{"key":"1570_CR88","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/166513a0","volume":"166","author":"D Keilin","year":"1950","unstructured":"Keilin D, Hartree EF (1950) Reaction of methaemoglobin with hydrogen peroxide. Nature 166:513\u2013514","journal-title":"Nature"},{"key":"1570_CR89","doi-asserted-by":"crossref","first-page":"9285","DOI":"10.1073\/pnas.90.20.9285","volume":"90","author":"J Balla","year":"1993","unstructured":"Balla J, Jacob HS, Balla G, Nath K, Eaton JW, Vercellotti GM (1993) Endothelial-cell heme uptake from heme proteins: induction of sensitization and desensitization to oxidant damage. Proc Natl Acad Sci USA 90:9285\u20139289","journal-title":"Proc Natl Acad Sci USA"},{"key":"1570_CR90","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/S0006-291X(74)80262-7","volume":"58","author":"PE Gurba","year":"1974","unstructured":"Gurba PE, Zand R (1974) Bilirubin binding to myelin basic protein, histones and its inhibition in vitro of cerebellar protein synthesis. Biochem Biophys Res Commun 58:1142\u20131147 S0006-291X(74)80262-7","journal-title":"Biochem Biophys Res Commun"},{"key":"1570_CR91","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1021\/bi00382a016","volume":"26","author":"SJ Morris","year":"1987","unstructured":"Morris SJ, Bradley D, Campagnoni AT, Stoner GL (1987) Myelin basic protein binds heme at a specific site near the tryptophan residue. Biochemistry 26:2175\u20132182","journal-title":"Biochemistry"},{"key":"1570_CR92","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1161\/ATVBAHA.110.206433","volume":"30","author":"E Nagy","year":"2010","unstructured":"Nagy E, Eaton JW, Jeney V, Soares MP, Varga Z, Galajda Z, Szentmiklosi J, Mehes G, Csonka T, Smith A, Vercellotti GM, Balla G, Balla J (2010) Red cells, hemoglobin, heme, iron, and atherogenesis. Arterioscler Thromb Vasc Biol 30:1347\u20131353. doi: 10.1161\/ATVBAHA.110.206433","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1570_CR93","doi-asserted-by":"crossref","first-page":"7094","DOI":"10.1016\/S0021-9258(19)68927-1","volume":"256","author":"JE Repine","year":"1981","unstructured":"Repine JE, Fox RB, Berger EM (1981) Hydrogen peroxide kills Staphylococcus aureus by reacting with staphylococcal iron to form hydroxyl radical. J Biol Chem 256:7094\u20137096","journal-title":"J Biol Chem"},{"key":"1570_CR94","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s12035-012-8364-8","volume":"47","author":"A Barateiro","year":"2013","unstructured":"Barateiro A, Miron VE, Santos SD, Relvas JB, Fernandes A, Ffrench-Constant C, Brites D (2013) Unconjugated bilirubin restricts oligodendrocyte differentiation and axonal myelination. Mol Neurobiol 47:632\u2013644. doi: 10.1007\/s12035-012-8364-8","journal-title":"Mol Neurobiol"},{"key":"1570_CR95","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10072-012-1101-2","volume":"34","author":"C Baracchini","year":"2013","unstructured":"Baracchini C, Atzori M, Gallo P (2013) CCSVI and MS: no meaning, no fact. Neurol Sci 34:269\u2013279. doi: 10.1007\/s10072-012-1101-2","journal-title":"Neurol Sci"},{"key":"1570_CR96","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1471-2202-12-60","volume":"12","author":"R Zivadinov","year":"2011","unstructured":"Zivadinov R, Weinstock-Guttman B, Pirko I (2011) Iron deposition and inflammation in multiple sclerosis. Which one comes first? BMC Neurosci 12:60. doi: 10.1186\/1471-2202-12-60","journal-title":"BMC Neurosci"},{"key":"1570_CR97","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/jcbfm.2013.31","volume":"33","author":"JM Valdueza","year":"2013","unstructured":"Valdueza JM, Doepp F, Schreiber SJ, van Oosten BW, Schmierer K, Paul F, Wattjes MP (2013) What went wrong? The flawed concept of cerebrospinal venous insufficiency. J Cereb Blood Flow Metab 33:657\u2013668. doi: 10.1038\/jcbfm.2013.31","journal-title":"J Cereb Blood Flow Metab"},{"key":"1570_CR98","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1093\/clinchem\/42.10.1589","volume":"42","author":"MR Langlois","year":"1996","unstructured":"Langlois MR, Delanghe JR (1996) Biological and clinical significance of haptoglobin polymorphism in humans. Clin Chem 42:1589\u20131600","journal-title":"Clin Chem"},{"key":"1570_CR99","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0005-2760(87)90125-1","volume":"917","author":"JM Gutteridge","year":"1987","unstructured":"Gutteridge JM (1987) The antioxidant activity of haptoglobin towards haemoglobin-stimulated lipid peroxidation. Biochim Biophys Acta 917:219\u2013223 0005-2760(87)90125-1 [pii]","journal-title":"Biochim Biophys Acta"},{"key":"1570_CR100","doi-asserted-by":"crossref","first-page":"12189","DOI":"10.1021\/bi970258a","volume":"36","author":"YI Miller","year":"1997","unstructured":"Miller YI, Altamentova SM, Shaklai N (1997) Oxidation of low-density lipoprotein by hemoglobin stems from a heme-initiated globin radical: antioxidant role of haptoglobin. Biochemistry 36:12189\u201312198. doi: 10.1021\/bi970258a","journal-title":"Biochemistry"},{"key":"1570_CR101","doi-asserted-by":"crossref","first-page":"3899","DOI":"10.1021\/bi0362626","volume":"43","author":"VV Bamm","year":"2004","unstructured":"Bamm VV, Tsemakhovich VA, Shaklai M, Shaklai N (2004) Haptoglobin phenotypes differ in their ability to inhibit heme transfer from hemoglobin to LDL. Biochemistry 43:3899\u20133906. doi: 10.1021\/bi0362626","journal-title":"Biochemistry"},{"key":"1570_CR102","doi-asserted-by":"crossref","first-page":"15819","DOI":"10.1523\/JNEUROSCI.3776-09.2009","volume":"29","author":"X Zhao","year":"2009","unstructured":"Zhao X, Song S, Sun G, Strong R, Zhang J, Grotta JC, Aronowski J (2009) Neuroprotective role of haptoglobin after intracerebral hemorrhage. J Neurosci 29:15819\u201315827. doi: 10.1523\/JNEUROSCI.3776-09.2009","journal-title":"J Neurosci"},{"key":"1570_CR103","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1751-553X.2007.00898.x","volume":"29","author":"K Carter","year":"2007","unstructured":"Carter K, Worwood M (2007) Haptoglobin: a review of the major allele frequencies worldwide and their association with diseases. Int J Lab Hematol 29:92\u2013110. doi: 10.1111\/j.1751-553X.2007.00898.x","journal-title":"Int J Lab Hematol"},{"key":"1570_CR104","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/j.1471-4159.1983.tb09058.x","volume":"41","author":"T Takeoka","year":"1983","unstructured":"Takeoka T, Shinohara Y, Furumi K, Mori K (1983) Impairment of blood\u2013cerebrospinal fluid barrier in multiple sclerosis. J Neurochem 41:1102\u20131108","journal-title":"J Neurochem"},{"key":"1570_CR105","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1002\/elps.201000171","volume":"31","author":"A Robotti","year":"2010","unstructured":"Robotti A, Natale M, Albo AG, Lis K, Perga S, Marnetto F, Gilli F, Bertolotto A (2010) Acute-phase proteins investigation based on lectins affinity capture prior to 2-DE separation: application to serum from multiple sclerosis patients. Electrophoresis 31:2882\u20132893. doi: 10.1002\/elps.201000171","journal-title":"Electrophoresis"},{"key":"1570_CR106","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1002\/eji.200939291","volume":"39","author":"G Galicia","year":"2009","unstructured":"Galicia G, Maes W, Verbinnen B, Kasran A, Bullens D, Arredouani M, Ceuppens JL (2009) Haptoglobin deficiency facilitates the development of autoimmune inflammation. Eur J Immunol 39:3404\u20133412. doi: 10.1002\/eji.200939291","journal-title":"Eur J Immunol"},{"key":"1570_CR107","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1179\/135100009X12525712409931","volume":"14","author":"SR Robinson","year":"2009","unstructured":"Robinson SR, Dang TN, Dringen R, Bishop GM (2009) Hemin toxicity: a preventable source of brain damage following hemorrhagic stroke. Redox Rep 14:228\u2013235. doi: 10.1179\/135100009X12525712409931","journal-title":"Redox Rep"},{"key":"1570_CR108","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/jcbfm.2009.19","volume":"29","author":"RC Li","year":"2009","unstructured":"Li RC, Saleem S, Zhen G, Cao W, Zhuang H, Lee J, Smith A, Altruda F, Tolosano E, Dor\u00e9 S (2009) Heme-hemopexin complex attenuates neuronal cell death and stroke damage. J Cereb Blood Flow Metab 29:953\u2013964. doi: 10.1038\/jcbfm.2009.19","journal-title":"J Cereb Blood Flow Metab"},{"key":"1570_CR109","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.3171\/2010.10.JNS10861","volume":"114","author":"L Chen","year":"2011","unstructured":"Chen L, Zhang X, Chen-Roetling J, Regan RF (2011) Increased striatal injury and behavioral deficits after intracerebral hemorrhage in hemopexin knockout mice. J Neurosurg 114:1159\u20131167. doi: 10.3171\/2010.10.JNS10861","journal-title":"J Neurosurg"},{"key":"1570_CR110","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1471-2202-14-58","volume":"14","author":"B Dong","year":"2013","unstructured":"Dong B, Cai M, Fang Z, Wei H, Zhu F, Li G, Dong H, Xiong L (2013) Hemopexin induces neuroprotection in the rat subjected to focal cerebral ischemia. BMC Neurosci 14:58. doi: 10.1186\/1471-2202-14-58","journal-title":"BMC Neurosci"},{"key":"1570_CR111","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.1111\/j.1582-4934.2008.00611.x","volume":"13","author":"N Morello","year":"2009","unstructured":"Morello N, Tonoli E, Logrand F, Fiorito V, Fagoonee S, Turco E, Silengo L, Vercelli A, Altruda F, Tolosano E (2009) Haemopexin affects iron distribution and ferritin expression in mouse brain. J Cell Mol Med 13:4192\u20134204. doi: 10.1111\/j.1582-4934.2008.00611.x","journal-title":"J Cell Mol Med"},{"key":"1570_CR112","doi-asserted-by":"crossref","first-page":"e20173","DOI":"10.1371\/journal.pone.0020173","volume":"6","author":"N Morello","year":"2011","unstructured":"Morello N, Bianchi FT, Marmiroli P, Tonoli E, Rodriguez MV, Silengo L, Cavaletti G, Vercelli A, Altruda F, Tolosano E (2011) A role for hemopexin in oligodendrocyte differentiation and myelin formation. PLoS One 6:e20173. doi: 10.1371\/journal.pone.0020173","journal-title":"PLoS One"},{"key":"1570_CR113","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.4049\/jimmunol.1203076","volume":"191","author":"S Rolla","year":"2013","unstructured":"Rolla S, Ingoglia G, Bardina V, Silengo L, Altruda F, Novelli F, Tolosano E (2013) Acute-phase protein hemopexin is a negative regulator of Th17 response and experimental autoimmune encephalomyelitis development. J Immunol 191:5451\u20135459. doi: 10.4049\/jimmunol.1203076","journal-title":"J Immunol"},{"key":"1570_CR114","first-page":"1","volume":"105","author":"J Balla","year":"1992","unstructured":"Balla J, Jacob HS, Balla G, Nath K, Vercellotti GM (1992) Endothelial cell heme oxygenase and ferritin induction by heme proteins: a possible mechanism limiting shock damage. Trans Assoc Am Physicians 105:1\u20136","journal-title":"Trans Assoc Am Physicians"},{"key":"1570_CR115","first-page":"711","volume":"152","author":"LJ Wang","year":"1998","unstructured":"Wang LJ, Lee TS, Lee FY, Pai RC, Chau LY (1998) Expression of heme oxygenase-1 in atherosclerotic lesions. Am J Pathol 152:711\u2013720","journal-title":"Am J Pathol"},{"key":"1570_CR116","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1089\/152308602753666343","volume":"4","author":"S Kourembanas","year":"2002","unstructured":"Kourembanas S (2002) Hypoxia and carbon monoxide in the vasculature. Antioxid Redox Signal 4:291\u2013299. doi: 10.1089\/152308602753666343","journal-title":"Antioxid Redox Signal"},{"key":"1570_CR117","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0002-9440(10)63365-2","volume":"165","author":"MH Kapturczak","year":"2004","unstructured":"Kapturczak MH, Wasserfall C, Brusko T, Campbell-Thompson M, Ellis TM, Atkinson MA, Agarwal A (2004) Heme oxygenase-1 modulates early inflammatory responses: evidence from the heme oxygenase-1-deficient mouse. Am J Pathol 165:1045\u20131053. doi: 10.1016\/S0002-9440(10)63365-2","journal-title":"Am J Pathol"},{"key":"1570_CR118","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1172\/JCI4165","volume":"103","author":"A Yachie","year":"1999","unstructured":"Yachie A, Niida Y, Wada T, Igarashi N, Kaneda H, Toma T, Ohta K, Kasahara Y, Koizumi S (1999) Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest 103:129\u2013135. doi: 10.1172\/JCI4165","journal-title":"J Clin Invest"},{"key":"1570_CR119","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1046\/j.1471-4159.2001.00507.x","volume":"78","author":"O Goldbaum","year":"2001","unstructured":"Goldbaum O, Richter-Landsberg C (2001) Stress proteins in oligodendrocytes: differential effects of heat shock and oxidative stress. J Neurochem 78:1233\u20131242","journal-title":"J Neurochem"},{"key":"1570_CR120","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s12031-007-0005-8","volume":"32","author":"T Stahnke","year":"2007","unstructured":"Stahnke T, Stadelmann C, Netzler A, Br\u00fcck W, Richter-Landsberg C (2007) Differential upregulation of heme oxygenase-1 (HSP32) in glial cells after oxidative stress and in demyelinating disorders. J Mol Neurosci 32:25\u201337 JMN:32:1:25 [pii]","journal-title":"J Mol Neurosci"},{"key":"1570_CR121","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1471-4159.2009.06160.x","volume":"110","author":"HM Schipper","year":"2009","unstructured":"Schipper HM, Song W, Zukor H, Hascalovici JR, Zeligman D (2009) Heme oxygenase-1 and neurodegeneration: expanding frontiers of engagement. J Neurochem 110:469\u2013485. doi: 10.1111\/j.1471-4159.2009.06160.x","journal-title":"J Neurochem"},{"key":"1570_CR122","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1471-4159.2010.06611.x","volume":"113","author":"A Brand","year":"2010","unstructured":"Brand A, Bauer NG, Hallott A, Goldbaum O, Ghebremeskel K, Reifen R, Richter-Landsberg C (2010) Membrane lipid modification by polyunsaturated fatty acids sensitizes oligodendroglial OLN-93 cells against oxidative stress and promotes up-regulation of heme oxygenase-1 (HSP32). J Neurochem 113:465\u2013476. doi: 10.1111\/j.1471-4159.2010.06611.x","journal-title":"J Neurochem"},{"key":"1570_CR123","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.brainres.2010.06.030","volume":"1349","author":"T Izawa","year":"2010","unstructured":"Izawa T, Yamate J, Franklin RJ, Kuwamura M (2010) Abnormal iron accumulation is involved in the pathogenesis of the demyelinating dmy rat but not in the hypomyelinating mv rat. Brain Res 1349:105\u2013114. doi: 10.1016\/j.brainres.2010.06.030","journal-title":"Brain Res"},{"key":"1570_CR124","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S1474-4422(11)70105-3","volume":"10","author":"M D\u2019haeseleer","year":"2011","unstructured":"D\u2019haeseleer M, Cambron M, Vanopdenbosch L, De Keyser J (2011) Vascular aspects of multiple sclerosis. Lancet Neurol 10:657\u2013666. doi: 10.1016\/S1474-4422(11)70105-3","journal-title":"Lancet Neurol"},{"key":"1570_CR125","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1177\/1352458513504252","volume":"19","author":"I Wens","year":"2013","unstructured":"Wens I, Dalgas U, Stenager E, Eijnde BO (2013) Risk factors related to cardiovascular diseases and the metabolic syndrome in multiple sclerosis\u2014a systematic review. Mult Scler 19:1556\u20131564. doi: 10.1177\/1352458513504252","journal-title":"Mult Scler"},{"key":"1570_CR126","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.65.1.56","volume":"65","author":"N Koch-Henriksen","year":"1998","unstructured":"Koch-Henriksen N, Bronnum-Hansen H, Stenager E (1998) Underlying cause of death in Danish patients with multiple sclerosis: results from the Danish Multiple Sclerosis Registry. J Neurol Neurosurg Psychiatry 65:56\u201359","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1570_CR127","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1093\/brain\/awh104","volume":"127","author":"H Bronnum-Hansen","year":"2004","unstructured":"Bronnum-Hansen H, Koch-Henriksen N, Stenager E (2004) Trends in survival and cause of death in Danish patients with multiple sclerosis. Brain 127:844\u2013850. doi: 10.1093\/brain\/awh104","journal-title":"Brain"},{"key":"1570_CR128","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1212\/WNL.0b013e3181d6b125","volume":"74","author":"RA Marrie","year":"2010","unstructured":"Marrie RA, Rudick R, Horwitz R, Cutter G, Tyry T, Campagnolo D, Vollmer T (2010) Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis. Neurology 74:1041\u20131047. doi: 10.1212\/WNL.0b013e3181d6b125","journal-title":"Neurology"},{"key":"1570_CR129","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/1742-2094-8-127","volume":"8","author":"B Weinstock-Guttman","year":"2011","unstructured":"Weinstock-Guttman B, Zivadinov R, Mahfooz N, Carl E, Drake A, Schneider J, Teter B, Hussein S, Mehta B, Weiskopf M, Durfee J, Bergsland N, Ramanathan M (2011) Serum lipid profiles are associated with disability and MRI outcomes in multiple sclerosis. J Neuroinflammation 8:127. doi: 10.1186\/1742-2094-8-127","journal-title":"J Neuroinflammation"},{"key":"1570_CR130","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1034\/j.1600-0404.2002.01334.x","volume":"106","author":"F Giubilei","year":"2002","unstructured":"Giubilei F, Antonini G, Di LS, Sormani MP, Pantano P, Antonini R, Sepe-Monti M, Caramia F, Pozzilli C (2002) Blood cholesterol and MRI activity in first clinical episode suggestive of multiple sclerosis. Acta Neurol Scand 106:109\u2013112 1o334 [pii]","journal-title":"Acta Neurol Scand"},{"key":"1570_CR131","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2217\/bmm.09.14","volume":"3","author":"A Torres","year":"2009","unstructured":"Torres A, Askari AD, Malemud CJ (2009) Cardiovascular disease complications in systemic lupus erythematosus. Biomark Med 3:239\u2013252. doi: 10.2217\/bmm.09.14","journal-title":"Biomark Med"},{"key":"1570_CR132","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jbspin.2010.07.016","volume":"78","author":"JF Boyer","year":"2011","unstructured":"Boyer JF, Gourraud PA, Cantagrel A, Davignon JL, Constantin A (2011) Traditional cardiovascular risk factors in rheumatoid arthritis: a meta-analysis. Jt Bone Spine 78:179\u2013183. doi: 10.1016\/j.jbspin.2010.07.016","journal-title":"Jt Bone Spine"},{"key":"1570_CR133","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1179\/1743132812Y.0000000051","volume":"34","author":"CF Christiansen","year":"2012","unstructured":"Christiansen CF (2012) Risk of vascular disease in patients with multiple sclerosis: a review. Neurol Res 34:746\u2013753. doi: 10.1179\/1743132812Y.0000000051","journal-title":"Neurol Res"},{"key":"1570_CR134","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1177\/1352458512437814","volume":"18","author":"RA Marrie","year":"2012","unstructured":"Marrie RA, Yu BN, Leung S, Elliott L, Caetano P, Warren S, Wolfson C, Patten SB, Svenson LW, Tremlett H, Fisk J, Blanchard JF (2012) Rising prevalence of vascular comorbidities in multiple sclerosis: validation of administrative definitions for diabetes, hypertension, and hyperlipidemia. Mult Scler 18:1310\u20131319. doi: 10.1177\/1352458512437814","journal-title":"Mult Scler"},{"key":"1570_CR135","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1177\/1352458513475833","volume":"19","author":"E Jadidi","year":"2013","unstructured":"Jadidi E, Mohammadi M, Moradi T (2013) High risk of cardiovascular diseases after diagnosis of multiple sclerosis. Mult Scler J 19:1336\u20131340. doi: 10.1177\/1352458513475833","journal-title":"Mult Scler J"},{"issue":"Suppl 5","key":"1570_CR136","doi-asserted-by":"crossref","first-page":"v8","DOI":"10.1093\/ndt\/gfg1034","volume":"18","author":"J Balla","year":"2003","unstructured":"Balla J, Vercellotti GM, Nath K, Yachie A, Nagy E, Eaton JW, Balla G (2003) Haem, haem oxygenase and ferritin in vascular endothelial cell injury. Nephrol Dial Transpl 18(Suppl 5):v8\u2013v12","journal-title":"Nephrol Dial Transpl"},{"key":"1570_CR137","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.pathophys.2010.04.002","volume":"18","author":"JS Alexander","year":"2011","unstructured":"Alexander JS, Zivadinov R, Maghzi AH, Ganta VC, Harris MK, Minagar A (2011) Multiple sclerosis and cerebral endothelial dysfunction: Mechanisms. Pathophysiology 18:3\u201312. doi: 10.1016\/j.pathophys.2010.04.002","journal-title":"Pathophysiology"},{"key":"1570_CR138","doi-asserted-by":"crossref","first-page":"32844","DOI":"10.1074\/jbc.M110.146076","volume":"285","author":"PL Fernandez","year":"2010","unstructured":"Fernandez PL, Dutra FF, Alves L, Figueiredo RT, Mourao-Sa D, Fortes GB, Bergstrand S, Lonn D, Cevallos RR, Pereira RM, Lopes UG, Travassos LH, Paiva CN, Bozza MT (2010) Heme amplifies the innate immune response to microbial molecules through spleen tyrosine kinase (Syk)-dependent reactive oxygen species generation. J Biol Chem 285:32844\u201332851. doi: 10.1074\/jbc.M110.146076","journal-title":"J Biol Chem"},{"key":"1570_CR139","doi-asserted-by":"crossref","first-page":"20221","DOI":"10.1074\/jbc.M610737200","volume":"282","author":"RT Figueiredo","year":"2007","unstructured":"Figueiredo RT, Fernandez PL, Mourao-Sa DS, Porto BN, Dutra FF, Alves LS, Oliveira MF, Oliveira PL, Graca-Souza AV, Bozza MT (2007) Characterization of heme as activator of Toll-like receptor 4. J Biol Chem 282:20221\u201320229. doi: 10.1074\/jbc.M610737200","journal-title":"J Biol Chem"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-014-1570-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00018-014-1570-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-014-1570-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T00:30:05Z","timestamp":1716510605000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00018-014-1570-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,7]]},"references-count":139,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["1570"],"URL":"https:\/\/doi.org\/10.1007\/s00018-014-1570-y","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,7]]}}}